Pfizer Inc. vs The Charles Schwab Corporation
Market cap comparison over time
Pfizer Inc.
$149.2B
Rank #104
The Charles Schwab Corporation
$154.3B
Rank #101
Market Cap Over Time
Key Moments
- The Charles Schwab Corporation overtook Pfizer Inc. by 2025
Year-by-Year Comparison
| Year | Pfizer Inc. | The Charles Schwab Corporation | Leader |
|---|---|---|---|
| 2026 | $149.2B | $154.3B | The Charles Schwab Corporation |
| 2025 | $137.3B | $172.6B | The Charles Schwab Corporation |
| 2024 | $136.4B | $126.3B | Pfizer Inc. |
| 2023 | $139.5B | $115.7B | Pfizer Inc. |
| 2022 | $237.5B | $137.7B | Pfizer Inc. |
| 2021 | $265.1B | $137.5B | Pfizer Inc. |
| 2020 | $159.1B | $85.8B | Pfizer Inc. |
| 2019 | $154.3B | $75.6B | Pfizer Inc. |
| 2018 | $165.8B | $64.9B | Pfizer Inc. |
| 2017 | $132.8B | $79.6B | Pfizer Inc. |
| 2016 | $114.6B | $60.7B | Pfizer Inc. |
| 2015 | $109.7B | $50.2B | Pfizer Inc. |
| 2014 | $102.5B | $45.6B | Pfizer Inc. |
| 2013 | $97.3B | $38.9B | Pfizer Inc. |
| 2012 | $77.1B | $21.2B | Pfizer Inc. |
| 2011 | $64.0B | $16.4B | Pfizer Inc. |
| 2010 | $49.7B | $24.5B | Pfizer Inc. |
| 2009 | $49.6B | $26.5B | Pfizer Inc. |
| 2008 | $45.8B | $22.5B | Pfizer Inc. |
| 2007 | $55.2B | $35.1B | Pfizer Inc. |
| 2006 | $60.1B | $25.1B | Pfizer Inc. |
| 2005 | $52.1B | $18.9B | Pfizer Inc. |
| 2004 | $58.3B | $15.3B | Pfizer Inc. |
| 2003 | $75.0B | $15.0B | Pfizer Inc. |
| 2002 | $63.7B | $13.7B | Pfizer Inc. |
| 2001 | $81.9B | $19.4B | Pfizer Inc. |
| 2000 | $93.5B | $35.6B | Pfizer Inc. |
| 1999 | $65.4B | $31.9B | Pfizer Inc. |
| 1998 | $83.3B | $23.4B | Pfizer Inc. |
| 1997 | $49.3B | $11.6B | Pfizer Inc. |
| 1996 | $27.1B | $5.9B | Pfizer Inc. |
| 1995 | $20.2B | $3.7B | Pfizer Inc. |
| 1994 | $12.1B | $2.1B | Pfizer Inc. |